Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137)

Synonyms: PF 05082566

Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human IgG2 monoclonal antibody targeting the T-cell costimulatory receptor 4-1BB/CD137. It can be used for the research of relapsed/refractory follicular lymphoma (FL), non-Hodgkin lymphomas (NHL). MW :142.78.

Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137)

Purity & Quality Control

Batch: A262001 Purity: 99% Protein concentration: 7.24mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human IgG2 monoclonal antibody targeting the T-cell costimulatory receptor 4-1BB/CD137. It can be used for the research of relapsed/refractory follicular lymphoma (FL), non-Hodgkin lymphomas (NHL). MW :142.78.

Product Details

CAS No. 1417318-27-4
Molecular Weight 142.78
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) | Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) supplier | purchase Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) | Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) cost | Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) manufacturer | order Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) | Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137) distributor